BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P100
Near historical high
vs 2Y Ago
47.7x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
2025396.87%
202460.77%
20238.33%
2022-34.26%
2021-0.68%
2020-67.88%
2019-7.55%
2018-53.92%
2017-19.29%
2016-28.19%